Questioning botulinum toxin for headache: Reality or illusion

Archives of Neurology

Volumn 65, Issue 1, 2008, Pages 151-152

  Roach, E S ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN; BOTULINUM TOXIN A;

ACETYLCHOLINE RELEASE; ARTICLE; CLINICAL TRIAL; HEADACHE; HUMAN; MIGRAINE; NEUROMUSCULAR SYNAPSE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TENSION HEADACHE;

BOTULINUM TOXINS; CHRONIC DISEASE; HEADACHE; HUMANS; MIGRAINE DISORDERS;

EID: 38349077319     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2007.24     Document Type: Article

References (16)

1. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A (Botox) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg. 2000;123(6):669-676.
2. Ashkenazi A, Silberstein S. Botulinum toxin type A for the treatment of headache: why we say yes. Arch Neurol. 2008;65(1):146-149.
3. Pakalnis A, Couch J. Headache therapy with botulinum toxin: form over substance. Arch Neurol. 2008;65(1):149-151.
4. Padberg M, de Bruijn SF, de Haan RJ, Tavy DL. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia. 2004;24(8):675-680.
5. Schulte-Mattler WJ, Krack P. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain. 2004;109(1-2):110-114.
6. Rollnik JD, Tanneberger O, Schubert M, et al. Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache. 2000;40(4):300-305.
7. Schmitt WJ, Slowey E, Fravi N, et al. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache. 2001;41(7):658-664.
8. Silberstein SD, Gobel H, Jensen R, et al. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized,placebo-controlled,parallel-group-study. Cephalalgia. 2006;26(7):790-800.
9. Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C; Botox CDH Study Group. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45(4):293-307.
10. Silberstein SD, Stark SR, Lucas SM, et al. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc. 2005;80(9):1126-1137.
11. Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin M, Silberstein S; Botox CDH Study Group. Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache. 2005;45(4):315-324.
12. Evers S, Vollmen-Haase J, Schwaag S, Rahmann A, Husstedt IW, Frese A. Botulinum toxin type A in the prophylactic treatment of migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2004;24(10):838-843.
13. Silberstein SD, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment: for the Botox Migraine Clinical Research Group. Headache. 2000;40(6):445-450.
14. Relja M, Poole A, Schoenen J, Pascual J, Lei X, Thompson C; European BoNTA Headache Study Group. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches. Cephalalgia. 2007;27(6):492-503.
15. Aurora S, Gawel M, Brandes J, Pokta S, Vandenburgh A; Botox North American Episodic Migraine Study Group. Botulinum toxin type A prophylactic treatment of episodic migraine: a randomized, double-blind, placebo controlled exploratory study. Headache. 2007;47(4):489-499.
16. Elkind AH, O'Carroll P, Blumenfeld A, DeGryse R, Dimitrova R; BoNTA-024-026-036 Study Group. A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis. J Pain. 2006;7(10):688-696.